Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
Trond Undheim, Program Director, MIT Startup Exchange
Procter & Gamble is looking for new approaches and technologies that can help them to address key business challenges/opportunities. The following innovation brief(s) will provide a high-level overview of specific business goals and needs, as well as a high-level overview of what they are looking for in a solution.
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
Matthew Decker
Global Technical Leader - Comfort and Biophysics Group,W.L. Gore & Associates
James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.
Nan-Wei Gong, Cofounder & CEO, figur8
Natan Linder, Founder, Tulip
Investing in the Drivers of the Future of Energy, Ben Sampson, Director, Energy, GE Ventures
Faurecia FCM Liquid Hydrogen & Fuel Cell Team seeks startup with solutions to make possible liquid hydrogen storage for mobile application.